Research ArticleArticle
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma
Suzanne C. Li, Kathryn S. Torok, C. Egla Rabinovich, Fatma Dedeoglu, Mara L. Becker, Polly J. Ferguson, Sandy D. Hong, Maria F. Ibarra, Katie Stewart, Elena Pope, Gloria C. Higgins, Ronald M. Laxer, Thomas Mason II, Robert C. Fuhlbrigge and Tracy Andrews for the CARRA Registry Investigators
The Journal of Rheumatology October 2019, jrheum.190311; DOI: https://doi.org/10.3899/jrheum.190311
Suzanne C. Li
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Kathryn S. Torok
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
C. Egla Rabinovich
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Fatma Dedeoglu
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Mara L. Becker
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Polly J. Ferguson
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Sandy D. Hong
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Maria F. Ibarra
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Katie Stewart
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Elena Pope
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Gloria C. Higgins
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Ronald M. Laxer
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Thomas Mason II
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Robert C. Fuhlbrigge
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
Tracy Andrews
From the Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Duke University School of Medicine, Durham, North Carolina; Boston Children’s Hospital, Boston, Massachusetts; Children’s Mercy Hospital, Kansas City, Missouri; University of Iowa Carver College of Medicine; University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa; Children’s Medical Center of Dallas and UT Southwestern, Dallas, Texas; The Ohio State University, Columbus, Ohio; Mayo Clinic, Rochester, Minnesota; University of Colorado–Denver and Children’s Hospital Colorado, Denver, Colorado; Rutgers University, School of Public Health, Newark, New Jersey, USA; University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry was supported by a grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award number RC2AR058934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. CARRA, Friends of CARRA, the Arthritis Foundation, and the Duke Clinical Research Institute also supported the CARRA Legacy Registry. This study was funded primarily by an innovative research grant from the Arthritis foundation (PI: SL). CARRA provided additional funding for data analysis (publication grant, PI: SL) and in-kind resources to support management and maintenance of the registry for the study, online meetings, and face-to-face meetings at annual meetings of CARRA and the American College of Rheumatology. Support for biobanking was provided by independent funding from The Nancy Taylor Foundation for Chronic Diseases Inc. (PI: KST, Children’s Hospital of Pittsburgh Pediatric Scleroderma Fund). S.C. Li, MD, PhD, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine at Seton Hall University; K.S. Torok, MD, UPMC Children’s Hospital of Pittsburgh; C.E. Rabinovich, MD, MPH, Duke University School of Medicine; F. Dedeoglu, MD, Boston Children’s Hospital; M.L. Becker, MD, MSCE, Children’s Mercy Hospital; P.J. Ferguson, MD, University of Iowa Carver College of Medicine; S.D. Hong, MD, University of Iowa Stead Family Children’s Hospital; M.F. Ibarra, MD, Children’s Mercy Hospital; K. Stewart, MD, Children’s Medical Center of Dallas and UT Southwestern; E. Pope, MD, University of Toronto and The Hospital for Sick Children; G.C. Higgins, MD, PhD, The Ohio State University; R.M. Laxer, MD, University of Toronto and The Hospital for Sick Children; T. Mason II, MD, Mayo Clinic; R.C. Fuhlbrigge, MD, PhD, University of Colorado–Denver, and Children’s Hospital Colorado; T. Andrews, MA, Rutgers University, School of Public Health. Address correspondence to Dr. S.C. Li, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave., Hackensack, New Jersey 07061, USA. E-mail: suzanne.li@hackensackmeridian.org. Accepted for publication September 30, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma
Suzanne C. Li, Kathryn S. Torok, C. Egla Rabinovich, Fatma Dedeoglu, Mara L. Becker, Polly J. Ferguson, Sandy D. Hong, Maria F. Ibarra, Katie Stewart, Elena Pope, Gloria C. Higgins, Ronald M. Laxer, Thomas Mason , Robert C. Fuhlbrigge, Tracy Andrews
The Journal of Rheumatology Oct 2019, jrheum.190311; DOI: 10.3899/jrheum.190311
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma
Suzanne C. Li, Kathryn S. Torok, C. Egla Rabinovich, Fatma Dedeoglu, Mara L. Becker, Polly J. Ferguson, Sandy D. Hong, Maria F. Ibarra, Katie Stewart, Elena Pope, Gloria C. Higgins, Ronald M. Laxer, Thomas Mason , Robert C. Fuhlbrigge, Tracy Andrews
The Journal of Rheumatology Oct 2019, jrheum.190311; DOI: 10.3899/jrheum.190311